Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alacramyn in pediatric scorpion sting envenomation
NCT01599923Phase 3Completed
- Sponsor
- Instituto Bioclon S.A. de C.V.
- Start
- May 2005
- Primary completion
- Jun 2006
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of centruroides (scorpion) immune F(ab')₂ (equine) in scorpion envenomation, sponsored by Instituto Bioclon S.A. de C.V. Primary endpoint: Resolution of clinically important systemic signs of scorpion envenomation at 4 hours. Started May 2005; status: completed.
02
Drugs
centruroides (scorpion) immune F(ab')₂ (equine)
03
Conditions
scorpion envenomation
Beyond the preview
Go deeper on NCT01599923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01599923.